- Home
- CAG vs CAI Comparison
CAG vs CAI Comparison
Compare CAG & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAG | CAI |
|---|---|---|
| Founded | 1919 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.0B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | CAG | CAI |
|---|---|---|
| Price | $16.69 | $25.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $19.50 | ★ $34.71 |
| AVG Volume (30 Days) | ★ 10.8M | 2.0M |
| Earning Date | 12-19-2025 | 02-12-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,234,500,000.00 | $649,062,000.00 |
| Revenue This Year | N/A | $77.57 |
| Revenue Next Year | N/A | $35.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 112.02 |
| 52 Week Low | $15.96 | $22.86 |
| 52 Week High | $28.52 | $42.50 |
Technical Indicators
Market Signals| Indicator | CAG | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | N/A |
| Support Level | $15.96 | N/A |
| Resistance Level | $17.01 | N/A |
| Average True Range (ATR) | 0.37 | 0.00 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 43.84 | 0.00 |
Price Performance
Historical ComparisonAbout CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.